313 results
SC14D9C
EX-2.1
CTIC
CTI BioPharma Corp
10 May 23
Written communication relating to third party tender offer
1:30pm
or material weakness in the design or operation of the internal control over financial reporting utilized by the Company; (2) any illegal act or fraud … to make any statement, that (in any such case) establishes a reasonable basis for the FDA to invoke its Fraud, Untrue Statements of Material Facts
8-K
EX-2.1
CTIC
CTI BioPharma Corp
10 May 23
Tender and Support Agreement
8:05am
or material weakness in the design or operation of the internal control over financial reporting utilized by the Company; (2) any illegal act or fraud … to make any statement, that (in any such case) establishes a reasonable basis for the FDA to invoke its Fraud, Untrue Statements of Material Facts
8-K
EX-10.2
ll9js28e9
4 Mar 22
Departure of Directors or Certain Officers
5:04pm